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Tuning the Matrix Metalloproteinase-1 Degradability of Peptide 
Amphiphile Nanofibers through Supramolecular Engineering
Yejiao Shi, a Daniela S. Ferreira, a Jayati Banerjee, a Andrew R. Pickford b and Helena S. Azevedo a *
Matrix metalloproteinases (MMPs) are a family of endopeptidases capable of degrading extracellular matrix (ECM) 
components. They are known to play crucial roles during the ECM turnover in both physiological and pathological 
processes. As such, their activities are utilized as biological stimuli to engineer MMP-responsive peptide-based 
biomaterials such as self-assembled peptide amphiphiles (PAs). Although previous studies have unveiled the role of PAs 
secondary structure on the mechanical and biological properties of their self-assembled nanostructures, the effect on the 
degradability of their assemblies by MMP-1 has not been reported. Herein, a series of PAs are designed and synthesized, 
all comprising the same MMP-1 cleavable domain but with variable structural segments, to decipher the role of PA’s 
secondary structure on the MMP-1 degradability of their assemblies. This study reveals a correlation between the MMP-1 
degradation efficiency and the β-sheet content of the self-assembled PA nanofibers, with the MMP-1 cleavability being 
significantly reduced in the PA nanofibers with stronger β-sheet characteristics. These results shed light on the role of 
supramolecular cohesion in PA assemblies on their hydrolysis by MMP-1 and open up the possibility to control the 
degradation rate of PA-based nanostructures by MMP-1 through tweaking their molecular sequences.
Introduction
Matrix metalloproteinases (MMPs) comprise a group zinc-
dependent endopeptidases that are responsible for the 
degradation of extracellular matrix (ECM) components, such as 
collagens, proteoglycans and glycoproteins.1 Their activities 
are low in normal physiological conditions but increase during 
the remodelling or repair processes and in inflamed or 
diseased tissues.2 For example, during the remodelling stage of 
wound healing, the upregulation of MMP-1 is crucial, since 
MMP-1 not only breaks down the proteins in the provisional 
ECM barrier to permit cell migration, but also mediates the 
balance between ECM synthesis and degradation.3 Other 
MMPs, such as MMP-2 and MMP-9, are found overexpressed 
in breast, colorectal, prostate and many other types of 
cancers, and are recognized as the most prominent 
proteinases associated with tumour progression and 
metastasis.4, 5 These abnormal MMP activities have been 
considered as attractive biological triggers to design 
responsive biomaterials with the capacity to exert their 
functions specifically and selectively.6-8
   Among the building blocks used for creating biomaterials, 
self-assembling peptide amphiphiles (PAs) developed by the 
Stupp laboratory have received considerable attention over 
the past decades due to their advantageous properties, such 
as biocompatibility, biodegradability, as well as design 
versatility over both the structure and function of their 
assemblies.9 Typically, a PA molecule consists of a hydrophobic 
alkyl tail covalently attached to a tuneable peptide segment. 
Through rational design, a wide variety of nanostructures, such 
as fibres, ribbons, belts and micelles, were observed in PA 
assemblies. These nanostructures have been explored in 
diverse medical applications, ranging from tissue engineering, 
regenerative medicine, immune modulation to drug delivery 
and disease diagnostics.9-11
   The incorporation of different MMP-cleavable peptide 
sequences into self-assembling PAs, have enabled the design 
of nanostructures with properties tailored for specific medical 
purposes. For instance, nanostructures assembled from PAs 
containing MMP substrates were explored to mimic the ECM 
degradation process for tissue engineering applications, a 
concept first proposed by Hubbell using polyethylene glycol 
(PEG) hydrogels crosslinked with MMP-sensitive peptides.12 
Based on this concept, Hartgerink’s group developed self-
assembled PA nanofiber networks, which could undergo cell-
mediated degradation with the incorporation of MMP-2 
cleavable sites into the PA molecules.13, 14 Inspired by these 
pioneering studies, our group engineered self-assembling 
membranes made of hyaluronic acid and MMP-1 substrate 
containing PAs.15 These membranes were shown to respond to 
the hydrolytic activities of both hyaluronidase and MMP-1, 
stimulate MMP-1 secretion by fibroblasts and interfere with 
the collagen deposition, which highlighted the ability of 
modulating certain cellular activities through ECM 
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engineering.15 Moreover, nanostructures assembled from 
MMP substrate containing PAs were also explored to respond 
to the activities of MMPs overexpressed at the tumour 
environment for cancer therapy. Through complexation of the 
anticancer drug cisplatin with the free carboxylates in a PA 
molecule, a cisplatin delivery system was developed based on 
a MMP-2 sensitive PA gel, which could release cisplatin when 
exposed to MMP-2.16 MMP-7 induced hydrogelation of PAs 
was also described.17 The designed PA was used as a 
hydrogelator precursor, which presented a sol-gel phase 
transition upon the removal of a gelation-preventing moiety in 
its sequence by MMP-7 proteolysis.17 The MMP-7 triggered 
hydrogelation of the PA was further proved to selectively 
initiate cancer cell death via exerting vital stress on cancer 
cells.18 A proof-of-concept design of MMP-2 sensitive PA 
nanostructures with potential as tumour targeted intracellular 
delivery vehicles was also reported by our group.19 These 
nanostructures were shown to selectively expose a cell-
penetrating peptide at their surface and undergo fibre-to-
micelle morphological transition upon degradation by MMP-
2.19
   These studies highlight the interest in exploiting MMP 
activities to induce desirable functions in self-assembling PA-
based biomaterials by selective degradation. To achieve 
controlled biological outcomes with these biomaterials, either 
promoting cell migration and growth, or regulating drug 
release, it is critical to optimize their degradation rate.20 Earlier 
studies by Hubbell’s group have identified candidate linear 
peptides for optimized degradation by MMP-1 and MMP-2, 
which were further used to enhance the degradation of PEG 
hydrogels and allow increased cellular infiltration for 
potentially more robust healing in vivo.21, 22 Several attempts 
were exploited to control the degradability of self-assembling 
peptide nanofibrous hydrogels by MMP enzymes mainly 
through the peptide primary structure (e.g. sequence 
modification of MMP substrates).23, 24 Recently, Ulijn and co-
workers reported a peptide design approach to tune the 
degradation kinetics of supramolecular peptide nanostructures 
by MMP-9.25 Peptides were designed with systematically 
modified amino acid sequences to control overall charge and 
order in the MMP-9 substrate region. As result of this 
systematic design, nanostructures with different secondary 
structures and morphologies (nanofibers, elongated worm-like 
micelles and spherical micelles) were formed by self-assembly, 
not being possible to isolate the effect of nanostructure 
morphology on MMP cleavability. In contrast, PA molecules 
are known to self-assemble into defined nanofiber structures 
whose rigidity and biological properties were shown to be 
regulated through modulation of their secondary structure.26-
29 However, the effect of PA’s secondary structure on their 
degradability by relevant proteases has not been investigated 
in detail. MMP-1 is a member of the collagenase family30 that 
includes MMP-8 and MMP-13, and has the ability to cleave 
interstitial collagens (and, to a much lesser extent, denatured 
collagen which is also known as gelatin)31, 32 leading to 
unwinding of the triple-helical structure and leaving the now 
unstructured substrate highly susceptible to gelatinases, such 
as MMP-2 and MMP-9. The ability of an MMP collagenase to 
breakdown triple helical collagen relies on the binding of an 
S10’ “exosite” within the enzyme’s hemopexin domain to a 
region C-terminal to the substrate’s scissile bonds.33 This 
specific interaction is believed to locally unwind the triple helix 
secondary structure allowing a single α-chain to enter the 
active site cleft of the catalytic domain which is too narrow to 
accommodate all three α-chains simultaneously.34 Herein, we 
hypothesize that the degradability of PA nanofibers by MMP-1 
can be tuned by controlling their internal supramolecular 
cohesion. To test this hypothesis, we performed a detailed 
study to elucidate the relationship between the secondary 
structure of self-assembled PA nanostructures and their MMP-
1 degradability.
Results and discussion
The specificity of MMP-1 for its substrates, either proteins or 
peptides, is typically influenced by the substrate sequences 
and their local secondary and tertiary structure.35 The regions 
containing protease substrates are expected to be flexible to 
facilitate access by the enzyme active site. The flexibility can 
be affected by the local secondary structure, which is 
determined by the primary sequence. The use of synthetic 
triple-helical peptides in previous studies has provided insights 
into the collagen degradation by MMPs,36 but the effect of 
hydrogen bonding network around the cleavage site and 
molecular packing has not been investigated in detail. In this 
study, we have selected PAs as a model self-assembling system 
as their self-assembly behaviour has been well established and 
enables systematic variations in their structural domains.
Design of MMP-1 Substrate Containing PAs with Variable 
Secondary Structures
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To verify our hypothesis that the molecular structure of PAs 
can be manipulated to control the degradation efficiency of 
their assemblies by MMP-1, a series of peptide molecules, all 
containing the MMP-1 substrate, but with the potential to 
adopting different secondary structures, were designed. As 
summarized in Table 1, all the peptide molecules were 
designed based on an octapeptide MMP-1 substrate 
(GPQG↓IWGQ), which was reported to be cleaved by MMP-1 
at the site between glycine (G) and isoleucine (I).21, 37 To 
ensure good solubility of all the designed peptide molecules in 
water, three charged lysine (K) residues were added to the C-
terminus of the octapeptide sequence. As for the N-terminus, 
several modifications were implemented. A peptide substrate 
(PS) was designed where the N-terminal amine was acetylated 
to eliminate the effect of additional charge at the N-terminus, 
while PA1 was capped with palmitic acid. The hydrophobic 
effect imparted by the 16-carbon alkyl tail is expected to drive 
the self-assembly of PA1 in aqueous solution by collapse of the 
hydrophobic tail in the core and presenting the lysine 
headgroup on the surface of the assemblies. To design PAs 
with variable secondary structure, a segment of six amino 
acids with different propensity of intermolecular hydrogen 
bonds was incorporated adjacent to the hydrophobic alkyl tail. 
In PA2, an α-helix promoting peptide sequence, composed of 
alanine residues (AAAAAA),38, 39 was incorporated next to the 
alkyl tail, while a well-known β-sheet forming peptide segment 
(VVVAAA) was used to generate PA3, which has been reported 
to form β-sheet nanofibers in our previous study.15 PA4 was 
designed by swapping the position of the β-sheet forming and 
MMP-1 cleavable peptide domains, with the assumption that 
PA4 may adopt a relatively weak or even disrupted β-sheet 
secondary structure as the β-sheet forming peptide segment is 
located away from the hydrophobic alkyl tail.40 Keeping the 
overall charge unchanged, and solely altering the secondary 
structure promoting segment as well as the location of the 
MMP-1 cleavable domain within the PA molecules, allow us to 
probe the effect of the internal packing of PA assemblies on 
the ability of MMP-1 to hydrolyse the peptide monomers at 
the G-I peptide bond.
In Silico Validation of the Designed PAs
To assess the theoretical potential of each designed peptide 
molecule to bind to the active site of MMP-1 when in a 
monomeric state, in silico modelling of the pre-hydrolysis 
(Michaelis) complex was performed. This assessment is 
particularly important for any peptide sequence which 
promotes, in the vicinity of the scissile bond, a defined 
conformation since the catalytic cleft can only accommodate 
substrates that are locally unstructured.34 The success of such 
analyses are dependent upon an accurate portrayal of specific 
enzyme-substrate interactions within the active site. 
Therefore, the likely conformation of the octapeptide 
substrate was established within the MMP-1 catalytic cleft by 
reference to crystal structures of the catalytic domain of MMP-
8, which is highly homologous with that of MMP-1 (Fig. S1A†), 
in complex with inhibitors that occupy either the S1’ pocket41 
or the S3 pocket42 (Fig. S1B, C†); together these pockets are 
the chief determinants of MMP-1 substrate specificity.43 Those 
prior analyses, when combined with the crystal structure of 
MMP-1,44 provided sufficient structural information for reliably 
positioning the [P3]Pro and [P1’]Ile residue sidechains into 
their respectively sub-sites, and for establishing a backbone 
conformation that places the scissile peptide bond in close 
proximity to the zinc ion and Glu residue that are both 
essential for MMP catalytic activity (Fig. 1A). Unfortunately, at 
3 residues long, the MMP-8 inhibitors used in previous crystal 
structures are too short to provide conformational information 
for the first or the last amino acids of the octapeptide. 
However, since these sites (P4 and P4’) confer no detectable 
substrate specificity in MMP-1,43 there are unlikely to be 
specific or extensive contacts between the catalytic domain 
and [P4]Gly or [P4’]Gln of the octapeptide. Hence, the 
conformation of these residues were not constrained in 
subsequent modelling studies.
Table. 1 Sequence and critical aggregation concentration (CAC) of the designed 
PS and PAs containing the MMP-1 cleavable peptide sequence (orange: 
hydrophobic alkyl tail; red: β-sheet or α-helix promoting peptide segment; green: 
MMP-1 cleavable peptide domain; blue: charged peptide headgroup).
# Sequence CAC
(mM)
PS CH3CONH-GPQGIWGQKKK-CONH2 2
PA1 C15H31CONH-GPQGIWGQKKK-CONH2 2
PA2 C15H31CONH-AAAAAAGPQGIWGQKKK-CONH2 0.04
PA3 C15H31CONH-VVVAAAGPQGIWGQKKK-CONH2 0.004
PA4 C15H31CONH-GPQGIWGQVVVAAAKKK-CONH2 0.06
Fig. 1  Models of peptide monomers bound into the catalytic cleft of MMP-1: model of 
the pre-hydrolysis, binary complex formed between the octapeptide GPQG↓IWGQ 
(where ↓ indicates the scissile peptide bond) and the catalytic domain of MMP-1 (A). 
The catalytic zinc ion (grey sphere), which is coordinated by three histidine (His) 
residues, polarizes the carbonyl group of the scissile peptide, and coordinates the 
water molecule (cyan sphere) that will initiate hydrolysis by nucleophilic attack of the 
carbonyl carbon (indicated by an asterisk). Hydrogen bonding to the neighbouring 
glutamate (Glu) makes the water a stronger nucleophile. The recognition sub-sites (S3 
and S1’) that principally determine cleavage specificity are annotated and illustrated 
with pale green surfaces; Modelled complexes of MMP-1 (in its compact state) bound 
to PS, PA1, PA2, PA3 and PA4, respectively (B-F). In each image, the MMP-1 surface is 
depicted with the catalytic domain, hemopexin domain and inter-domain linker 
coloured pale green, pale blue and grey, respectively. Each peptide is shown space-
filled, with a colour scheme identical to that in Table 1.
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   The octapeptide extends sufficiently far from the catalytic 
cleft that the tri-lysine C-terminal imparts no appreciable steric 
hindrance on binding for either PS or any of the PAs (Fig. 1B-F). 
As expected, due to its unbranched structure, the palmitic acid 
tail at the N-terminal of each PA substrate is also readily 
accommodated into each model of MMP-1 in complex with a 
monomeric peptide. However, it is apparent that, particularly 
for PA1 and PA4, the close proximity of the fatty acid chain to 
the enzyme may preclude binding when these peptides 
successfully assemble into nanofibers or any other 
nanostructures (Fig. 1C-F). For PA2-PA4, the secondary 
structure elements could also be introduced without 
encountering any steric hindrance with either domain of 
MMP-1 (Fig. 1D-F), and without straining the established 
conformation of the octapeptide substrate within the active 
site, as judged by the overall potential energy of the system, 
and the lack of unrealistically-close non-bonded contacts; it is 
particularly notable that the AAAAAA segment in PA2 has the 
potential to form an α-helix (which is comparatively bulky) 
without hindering binding of the more-extended scissile 
sequence into the MMP-1 catalytic cleft. Having established 
that the N-terminal palmitic acid adduct, the C-terminal tri-
lysine sequence, and the engineered secondary structure 
elements were unlikely to interfere with the MMP-1 binding 
to, and hence cleavage of, the designed monomeric peptide 
molecules, we have proceeded with synthesis of each peptide 
and subsequent structural and MMP-1 degradability 
characterizations.
Synthesis, Self-assembly and Structure Characterization of the 
Designed PAs
The designed peptide molecules were then successfully 
synthesized and purified. Their mass and purity were 
confirmed by electrospray ionization mass spectrometry (ESI-
MS) and analytical reverse phase high performance liquid 
chromatography (RP-HPLC), respectively (Fig. S2-S7†). Critical 
aggregation concentration (CAC) of PAs is the concentration 
above which their self-assembly is triggered. To probe the 
transition of PA monomers into assembled structures, Nile Red 
assay was performed firstly. Nile Red is a hydrophobic dye with 
high affinity to the hydrophobic aggregation pocket.45 In 
hydrophilic environment, it has a weak fluorescence, while in 
hydrophobic environment, it exhibits an increased 
fluorescence and a pronounced blue shift.45 When mixed with 
various concentrations of PA solutions, Nile Red tends to 
partition into the hydrophobic core once any PA assemblies 
appear. Thus, the CAC of PAs can be determined at the point 
where there is a sharp increase in the fluorescence intensity 
and a blue shift in the emission peak of Nile Red.46 Knowing 
the CAC values for each PA and PS, the secondary structure of 
both monomers (< CAC) and assemblies (> CAC) was analysed 
by circular dichroism (CD) spectroscopy. In addition, the 
Fig. 2 Structure characterization and self-assembly of the designed PS and PAs in water: CD spectra of PS, PA1, PA2, PA3 and PA4 in the monomeric state (M, solid 
line, prepared at concentration < CAC) and their diluted aggregates (D, dashed line, prepared at concentration > CAC first and then diluted to the same concentration 
as in the monomeric state) at pH 7 and pH 10 displaying different secondary structures; representative TEM images of PS, PA1, PA2, PA3 and PA4 showing various 
fibrous nanostructures at pH 7, and also pH 10 (inserted images with dash line border); fluorescence of ThT in the presence of PS, PA1, PA2, PA3 and PA4 nanofibers 
in water at pH 7 showing differences in the β-sheet content within the various nanofibers.
Page 4 of 12Biomateri ls Science
B
io
m
at
er
ia
ls
S
ci
en
ce
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
is
he
d 
on
 2
4 
Se
pt
em
be
r 
20
19
. D
ow
nl
oa
de
d 
by
 Q
ue
en
 M
ar
y,
 U
ni
ve
rs
ity
 o
f 
L
on
do
n 
on
 9
/2
4/
20
19
 4
:5
4:
04
 P
M
. 
View Article Online
DOI: 10.1039/C9BM00949C
Journal Name  ARTICLE
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 5
Please do not adjust margins
Please do not adjust margins
morphology of the assemblies was visualized under TEM. β-
sheet content and stability of the assemblies against dilution 
were also examined by thioflavin T (ThT) assay and Nile Red 
assay, respectively.
    Even through lacking the hydrophobic alkyl tail and 
secondary structure promoting peptide segment, PS exhibited 
a relatively weak self-assembly ability with a high CAC 
determined at 2 mM (Fig. S8A†). Accordingly, TEM images of 
PS at 5 mM and pH 7 showed short fibrous nanostructures 
(Fig. 2). The self-assembly behaviour of PS at these conditions 
is largely attributed to its amphipathic structure, with the 
MMP-1 peptide substrate being relatively hydrophobic 
compared to the positively charged lysine domain at pH 7. 
However, CD analysis revealed a random coil conformation at 
pH 7, which was maintained at pH 10 despite the lysine 
residues being mostly deprotonated (neutral) at this pH. In 
addition, the short self-assembled fibres observed for PS were 
not stable enough to resist the effect of dilution (Fig. 3B). This 
was further confirmed by the CD spectrum of the diluted 
aggregates displaying a random coil conformation at pH 7, 
similar to the monomer state (Fig. 2).
    With the addition of the hydrophobic alkyl tail, PA1 was 
observed to form relatively longer but sparse nanofibers at pH 
7 (Fig. 2) once above its CAC (2 mM, Fig. S8B†). At pH 7, the 
hydrophobic collapse of the alkyl tails is hindered by the 
repulsive electrostatic forces derived from the positively 
charged lysine headgroup, preventing the formation of β-sheet 
structures below the CAC and the growth of PA1 nanofibers. 
However, at pH 10, with the lysine-rich domain at one end of 
the PA1 molecule being mostly deprotonated, a β-sheet 
secondary structure was observed for the PA1 monomers and 
long and intertwined nanofibers were detected under TEM 
(Fig. 2). Dilution of PA1 solutions prepared above the CAC at 
pH 7 showed the presence of aggregated structures (Fig. 3A), 
indicating that once formed, the PA1 nanofibers are stable 
against dilution. In fact, a β-sheet secondary structure was also 
observed for the diluted PA1 aggregates, instead of the 
random coil conformation displayed by its monomers at pH 7 
(Fig. 2), suggesting stronger internal cohesion in PA1 
nanofibers compared to the ones formed by PS. Similar 
behaviour was observed for another PA system.47
    Similar to PA1, PA2 also self-assembled into nanofibers 
despite also presenting a random coil conformation at pH 7 
(Fig. 2). However, the PA2 nanofibers were longer and denser 
compared to the ones formed by PA1 and its CAC was 
relatively lower (0.04 mM, Fig. S8C†). The enhanced self-
assembly ability of PA2 may be explained by the introduction 
of the hydrophobic α-helix promoting sequence AAAAAA, 
which strengths the hydrophobic force among the PA2 
molecules for competing with the electrostatic repulsive forces 
of the charged domain. Even though high density of nanofibers 
were observed at pH 10, a combination of α-helix and β-sheet 
secondary structures was detected in the CD spectrum (Fig. 2). 
Using an online secondary structure analysis tool, BeStSel,48, 49 
for the PA2 monomers, revealed 20% of helical content. It 
indicates that the α-helix promoting peptide segment endows 
PA2 with a slight trend to adopt helical secondary structure. 
The existence of mixed secondary structures in PAs has been 
reported before.26 Furthermore, unlike PA1, PA2 nanofibers 
were not stable against dilution (Fig. 3B) and its diluted 
aggregates displayed a predominant random coil conformation 
(Fig. 2), which suggests, to some extent, the instability of PA2 
nanofibers. The slightly twisted helical conformation of PA2 
may lead to a less packed and disordered fibres.
    Comprising the well-known β-sheet forming peptide 
segment (VVVAAA) used in PA molecules, PA3 exhibited a 
comparatively low CAC of 0.004 mM (Fig. S8D†), 
demonstrating significant self-assembly ability. Short 
nanofibers were observed to form in high density (Fig. 2), 
which is consistent with what we have reported in our 
previous study.15 As expected, due to the presence of the β-
sheet forming peptide segment, PA3 monomers adopted a 
defined β-sheet secondary structure at pH 7, which was 
enhanced at pH 10. In addition, the short nanofibers were 
observed to resist to the dilution effect (Fig. 3A). CD data for 
diluted PA3 aggregates (Fig. 2) also confirms the persistence of 
β-sheet conformation upon dilution with the positive band 
being more intense compared to PA3 monomers, despite 
being measured at the same concentration. The higher 
intensity of the β-sheet signal is an indicator of increased β-
sheet content once stable assemblies are formed. These 
results are supported by the study from the Stupp laboratory, 
in which site-directed spin labelling and electron paramagnetic 
resonance spectroscopy were used to probe the internal 
dynamics of PA nanofibers.50 It was found that PA molecules 
assembled within strong β-sheet nanofibers have slow 
dynamics and minimal structural instability as a result of the 
hydrogen bonding network that immobilizes the molecules 
into a stable supramolecular configuration.50 In PA4, in which 
the positions of the β-sheet forming peptide segment and 
MMP-1 peptide substrate were switched compared to PA3, its 
structure properties and self-assembly behaviour were 
observed to change. More specifically, an increased CAC (0.06 
mM, Fig. S8E†) was needed to drive the self-assembly of PA4 
into long and straight nanofibers (Fig. 2). These nanofibers 
were stable against dilution (Fig. 3A) and exhibited a β-sheet 
conformation once assembled (Fig. 2). It is likely that by 
placing the β-sheet forming peptide segment near to the 
charged lysine domain, the electrostatic repulsive force of the 
lysine domain is compromised by the hydrogen bonding of the 
β-sheet forming peptide segment, resulting in the reduction of 
structural curvature for the PA4 assemblies and hence the 
formation of long and straight nanofibers. However, since the 
MMP-1 substrate peptide domain was placed closer to the 
hydrophobic alkyl tail, the rigid structure of the proline and the 
steric hindrance from the tryptophan are likely to prevent 
hydrogen bond formation between the amide backbones, 
which are at the core of the PA4 molecules and necessary for 
the β-sheet stabilization. As a result, a random coil 
conformation was observed for the PA4 monomer at pH 7 (Fig. 
2). These results are in agreement with earlier studies, which 
demonstrated that sequence modifications at the alkyl tail and 
peptide headgroup interface of PAs could strongly influence 
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the hydrogen bonding and hence their nanostructural 
morphology.26
    To further confirm the secondary structure of the self-
assembled PA nanofibers provided by CD analysis, thioflavin-T 
(ThT) assay was performed to examine the presence of β-
sheets in the assemblies.51 ThT is a fluorescence dye that 
increases its emission fluorescence when binding to β-sheet 
rich structures.52 As shown in Fig. 2, significant fluorescence 
enhancement was observed in the PA3 and PA4 nanofibers, 
confirming their dominant β-sheet content. In contrast, the 
fluorescence in the PS nanofibers was just slightly higher than 
that of the blank ThT solution, indicating the absence of β-
sheets in these nanofibers. PA1 nanofibers largely increased 
the ThT fluorescence, while only minor increase was observed 
for the PA2 nanofibers, implying less β-sheet content as a 
result of the combined conformation within the PA2 
assemblies. These observations are in agreement with the CD 
results.
In summary, the designed PS and PAs could all self-assemble 
into fibrous nanostructures at pH 7 once above their 
corresponding CACs. However, only the PA1, PA3 and PA4 
nanofibers possess pronounced β-sheet secondary structure. 
The short fibrous nanostructures formed by PS display an 
unstable random coil conformation, while the long nanofibers 
of PA2 possess combined secondary structures. The designed 
PS and PAs, with similar peptide sequence but distinct 
structure properties and self-assembly behaviours (Fig. 2 & 3), 
were further utilized as probes to investigate the effect of 
supramolecular cohesion within their self-assembled 
nanofibers on MMP-1 degradation efficiency.
Degradation of PA Nanofibers by MMP-1
To allow direct comparison, all peptide samples (PS and PAs) 
were prepared at same concentration of 0.5 mM before being 
incubated with 20 nM active MMP-1 at 37 oC. At this 
concentration, PS and PA1 should be in their monomeric state, 
while PA2, PA3 and PA4 should be assembled in the form of 
nanofibers, according to their CAC values (Table 1). 
Additionally, PS and PA1 solutions were also prepared at 5 mM 
to ensure the formation of nanofibers. The MMP-1 
degradation activity was then monitored overtime by RP-HPLC. 
Two peptide fragments are expected as result of MMP-1 
cleavage of all PAs and PS. We have selected the expected C-
terminal peptide fragment (PF, NH2-IWGQKKK-CONH2) from 
PS, PA1, PA2 and PA3 MMP-1 hydrolysis to monitor 
degradation. PF was synthesized and could be easily detected 
in the HPLC trace at around 13 min (Fig. S7B†). Using different 
PF concentrations, a calibration curve was constructed (Fig. 
S12†) and used to quantify the degradation efficiency.
Effect of Hydrophobic Alkyl Tail. As shown in Fig. 4, evident 
changes were observed in the RP-HPLC spectrum of PS 
monomer sample after being incubated with active MMP-1 for 
24 h, with one peak around 15 min decreasing (indicated with 
red arrow), while another peak at approximately 13 min 
increasing (indicated with green arrow). The increasing peak 
was collected and analysed by ESI-MS, and the detected mass 
corresponds to the mass of PF, the expected C-terminal 
peptide fragment resulting from MMP-1 degradation (Fig. 
S9†). For the sample containing the PA1 monomers, the 
increasing peak with shorter elution time appearing around 13 
min was also observed (Fig. 4). However, the intensity of the 
peak was not as high as that of the PS monomers. As shown in 
Fig. 4, nearly 95.00% of PS monomers were degraded by MMP-
1 after 24 h, while only 16.33% degradation was achieved for 
PA1 monomers. These results indicate that conjugating a 
hydrophobic alkyl tail to the N-terminus of the MMP-1 
cleavable peptide segment could decrease, to some extent, its 
MMP-1 degradability. Even though the in silico modelling 
results indicate that productive MMP-1:peptide complexes are 
possible in each case, i.e. they are not prevented by steric 
hindrance between the enzyme and structural moieties 
Fig. 3 Stability examination of PA and PS nanofibers: the maximum fluorescence 
emission wavelength of Nile Red remains for PA1, PA3 and PA4 nanofibers (A) 
and red-shifted for PA2 and PS nanofibers (B) upon dilution, indicating stable 
nanofibers and unstable nanofibers respectively.
Fig. 4 MMP-1 degradation of PS and PA1 monomers, as well as PA1 and PA2 
nanofibers: analytical RP-HPLC spectra (selected elution time range) of 0.5 mM 
PS, PA1, PA2 and 5 mM PA1 before and after incubation with 20 nM active 
MMP-1 in TCNB buffer (pH 7) at 37 ˚C for 24 h; calculated MMP-1 degradation 
efficiency of both PS and PA1 monomers, as well as PA1 and PA2 nanofibers, 
measured as cleavage percentage.
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flanking the central GPQG↓IWGQ peptide, it is also possible 
that other interactions may interfere with peptide binding or 
active site availability. For example, given the hydrophobic 
nature of the palmitic acid chain, it is possible that it may 
interfere with productive substrate binding by partially 
occupying the S3 or S1' pockets which are themselves non-
polar in nature; thus it acts as a competitive inhibitor. 
Alternatively, the palmitic acid group may also interact with 
the enzyme outside of the active site, perhaps subtly changing 
the way the substrate lies in the catalytic cleft, and therefore 
reducing the turnover rate.
Effect of Self-assembly. Upon self-assembly, the MMP-1 
degradability of PA1 nanofibers (5 mM) was shown to be even 
more decreased (0.21%) compared with the PA1 monomers 
(0.5 mM) (Fig. 4). To assess if the substrate concentration was 
a limiting factor for the reduced degradation efficiency, the 
degradation of PS nanofibers was also examined at 5 mM (Fig. 
S10†). The results indicate that the amount of MMP-1 used is 
still sufficient for degrading a significant amount of PS, 
confirming that the lower degradation rate of PA1 nanofibers 
is due to reduced availability of PA1 monomers for enzyme 
cleavage and not solely to concentration effects. Self-assembly 
induced protease resistance has already been reported in 
previous studies and explained by the inaccessibility of the 
protease cleavable domain in the self-assembled 
nanostructures for the effective protease cleavage.53
Effect of Secondary Structure. By comparing the MMP-1 
degradability of all self-assembled nanofibers, from PA1 to 
PA4, the MMP-1 degradability of PA nanofibers was found to 
be secondary structure dependent. According to our 
observations, the β-sheet nanofibers assembled from PA3 and 
PA4, both containing the well-known β-sheet forming domain, 
exhibited extreme resistance to MMP-1 degradation as no 
peptide fragments were detected within 72 h (Fig. S11†). 
Similarly, the MMP-1 degradation could be barely detected for 
the β-sheet nanofibers formed by PA1 within 24 h (Fig. 4), 
even though it lacks the β-sheet forming domain and adopted 
a random coil conformation below the CAC. In contrast, PA2, 
with 20% helical content, displayed a slightly increased 
degradability by MMP-1 after 24 h (3.22%, Fig. 4). A possible 
explanation could be degree of the internal order within the 
different nanofibers. The relatively loose internal packing of 
the PA2 nanofibers, indicated by the change in their secondary 
structure induced by dilution (Fig. 2), suggests their dynamic 
behaviour and the dissociation of individual PA2 monomers 
from the nanofiber. In this scenario, MMP-1 is able to cleave 
the dissociated monomers, shifting the equilibrium in favour of 
the monomers. Consecutive hydrolysis of free peptide 
monomers leads to defects in the fibre packing and integrity. 
The weaker supramolecular cohesion in nanofibers self-
assembled from AAAAAA containing PAs was also reported in 
previous study, confirmed by the exchange of PA molecules 
between fibres observed by stochastic optical reconstruction 
microscopy.54 The β-sheet PA3 and PA4 nanofibers are more 
stable, requiring more time to observe an equilibrium (Fig. 
S11†). Collagenases, such as MMP-1, are generally known for 
degrading interstitial collagens (Coll I, II and III). However, they 
can also break down some non-triple helical substrates 
although with lower efficiency.34 Fibrillar collagen is composed 
of associated individual collagen molecules consisting of three 
α chains in a helical conformation.55, 56 Each triple helix 
measures 300 nm in length and 1.5 nm in diameter.34 Studies 
on the crystal structure of MMP-1 revealed a substrate binding 
site with the shape of a groove 5 Å wide, indicating that the 
dimensions of triple-helical collagen are too large to fit in the 
MMP-1 substrate binding site.34 It is thus unlikely that the PA 
nanofibers would fit into the MMP-1 active site and forming a 
stable enzyme:substrate complex, as the peptide sequence 
surrounding the scissile bond must form backbone hydrogen 
bonds with the outer strand of the catalytic domain's β-sheet. 
These interactions cannot take place if this peptide sequence 
is involved in intermolecular interactions with other peptides, 
and/or if steric hindrance from neighbouring peptides in the 
nanofiber prevents a close approach of the enzyme. Work 
performed by Gregg Fields and collaborators has shed light 
into the mechanisms by which MMPs cleave native collagen.36 
Instrumental in these studies were the use of model substrates 
(triple helical peptides containing potential cleavage sites) and 
MMP mutants.33 It was demonstrated that MMP-1 is able to 
unfold the triple helix of collagen and cleave the strands of the 
triple helix.34 However, the unfolding capacity of MMP-1 may 
not been applicable to the β-sheet conformations, which are 
maintained through intermolecular hydrogen bonding, instead 
of the intramolecular hydrogen bonds in helical structures.
Experimental Section
In Silico Modelling of MMP-1:Peptide Binding
Models of the binary pre-hydrolysis (Michaelis) complexes 
formed between MMP-1 and monomeric peptides were 
generated using the program CNS using a standard x-ray 
crystallography force-filed supplemented with bespoke 
topology and parameter description for the N-terminal 
palmitic acid adduct, and employing cartesian molecular 
dynamics-based simulated annealing protocols with 
conjugates-gradient minimisation.57 The non-bonded 
“switching” option was employed in order to smoothly 
truncate the attractive component of the van der Waals 
potential to zero at an inter-atomic distance of between 6.5 
and 7.5 Å. Inter-atomic (∁α-∁α) distance restraints and 
dihedral angle restraints were employed to maintain the 
approximate tertiary structure of MMP enzyme domains. 
    An initial model of MMP-1 in complex with the hexapeptide 
PQGIWG was generated from the x-ray coordinates of the 
MMP-8 catalytic domain (MMP-8∆HPX) in complex with the 
synthetic inhibitors Pro-Leu-Gly-hydroxamate42 and 3-
mercapto-2-benzylpropanoyl-Ala-Gly-NH241 (PDB accession 
codes 1JAN and 1JAO, respectively). Initially, the hydroxamate 
and mercaptomethylene moieties were deleted, and the 
bridging peptide bond was introduced, whilst harmonically 
restraining the remaining heavy atoms, to generate a MMP-
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8∆HPX:PLG↓FAG complex, where ↓ indicates the scissile bond. 
The desired MMP-1:PQG↓IWG complex structure was then 
generated by superposition with the crystal structure of MMP-
1 (accession code 2CLT),44 mutation of three side chains 
(L[P2]Q, F[P1’]I and A[P2’]W), and simulated annealing of the 
resultant conformation. In subsequent calculations, the 
conformation of this PQG↓IWG hexapeptide within the MMP-1 
active site was restrained with intramolecular dihedral angle 
restraints and intermolecular distance restraints. Outside of 
this region, secondary structure elements within the PAs were 
imparted with typical φ and ψ dihedral (torsion) angle 
restraints. In addition, α helical regions were further stabilised 
by inter-atomic distance restraints typical of (i, i+4) hydrogen 
bonds. No torsional restraints were placed on the tri-lysine and 
palmitic acid moieties, so their conformations were 
determined largely by steric repulsion.
    All images regarding the in silico modelling were produced 
using the program PyMol.58
Peptide Synthesis and Purification
All the peptides used in this study were synthesized in a 
Liberty Blue automated microwave peptide synthesizer (CEM) 
using the standard fluorenylmethyloxycarbonyl (Fmoc)-based 
solid phase peptide synthesis method. Briefly, 4-
methylbenzhydrylamine (MBHA) rink amide resin was used as 
the solid support to start each synthesis. Amino acid coupling 
cycles were performed with a mixture of Fmoc-amino acid / 1-
hydroxybenzotriazole (HOBt) / N,N’-diisopropylcarbodiimide 
(DIC) at a molar ratio of 4:4:4, relative to the resin. Fmoc 
deprotections were performed with 20% (v/v) piperidine in 
dimethylformamide (DMF) for 10 min twice. Palmitic acid 
(C16H32O2) was manually coupled to the peptide N-terminus 
amine for obtaining PA molecules. Coupling was performed 
overnight under the same conditions as for the Fmoc-amino 
acids while acetylation of the N-terminus was performed for 
the PS by shaking the peptide-bound resin with acetic 
anhydride (10% in DMF) for 20 minutes twice. The final 
coupling reaction was monitored with Kaiser test to confirm 
the lack of free amines. PAs and PS were then cleaved from 
the resin with a mixture of trifluoroacetic acid (TFA) / 
triisopropylsilane (TIS)/ H2O at a volume ratio of 95:2.5:2.5 for 
2 h with simultaneous removal of all the protecting groups. 
The cleavage solution was then collected and the excess TFA 
removed by rotary evaporation. Cold diethyl ether was added 
to precipitate the peptide product, which was then collected, 
washed again with cold diethyl ether and dried under vacuum 
overnight. Mass of the crude product was analysed via 
electrospray ionization mass spectrometry (ESI-MS, Agilent).
    Peptide purification was performed in an AutoPurification 
System (Waters) using a preparative reverse-phase (RP) C18 
column (XBridge, 130 Å, 5 μm, 30 x150 mm, Waters) and a 
gradient of H2O / Acetonitrile (ACN) (0.1% TFA) as mobile 
phase. Fractions containing the PAs were automatically 
collected when the exact mass signals were detected by a 
single quadrupole mass detector (SQ Detector 2, Waters). The 
collected PA fractions were concentrated first by rotary 
evaporation, then lyophilized and stored at -20 oC until further 
use.
    Mass confirmation and purity of all peptides were analysed 
(1 mg/mL) via ESI-MS and by high-performance liquid 
chromatography (HPLC, Alliance, Waters), equipped with an 
analytical RP C18 column (XBridge, 130 Å, 3.5 μm, 4.6 x150 
mm, Waters) and a UV detector set at 220 nm.
Critical Aggregation Concentration (CAC)
The CAC of PAs was determined according to a previous 
reported protocol.46 Briefly, a hydrophobic solvatochromic 
dye, Nile Red, was dissolved in acetone and aliquoted to 
Eppendorf tubes before being left in a dark place to generate a 
dry film at room temperature. Various concentrations of PA 
solutions, ranging from 100 nm to 10 mM, were then prepared 
and added to the Eppendorf tubes to dissolve the Nile Red dry 
film to a final concentration of 1 μM. After being aged 
overnight, each solution was analysed on a LS55 fluorescence 
spectrometer (PerkinElmer) with a fixed excitation wavelength 
of 550 nm. Fluorescence emission spectrum with a range from 
580 nm to 720 nm was then obtained for each solution and its 
maximum intensity and corresponding wavelength were 
determined and plotted as function of the logarithm PA 
concentration. The CAC of each PA was determined at the 
point where there is a sharp increase in the fluorescence 
intensity and a blue-shift of the emission maximum.
Stability Test
The stability of the PA assemblies against dilution was tested 
using the Nile Red assay. PA solutions were prepared by 
dissolving the PAs above their CACs firstly. After being 
incubated with the dry Nile Red film overnight, the 
fluorescence emission spectrum of each solution was recorded 
on a LS55 fluorescence spectrometer as described above. A 10-
fold dilution of each solution was then prepared in Milli-Q 
water and its fluorescence emission spectrum was recorded 
immediately. The red-shift in the emission maximum of diluted 
sample (< CAC) is considered as occurrence of the disassembly 
process, indicating the instability of the PA assemblies.
Circular Dichroism (CD)
The secondary structure of PAs was characterized in a 
Chirascan CD spectrometer (Applied Photophysics) in the far 
UV region (190 nm – 280 nm) at 25 oC. Samples were prepared 
both in the monomer state by directly dissolving the PA below 
its CAC, and in the self-assembled state by dissolving the PA 
above its CAC first, followed by dilution before measurement. 
Each prepared solution was loaded into a 1 mm path length 
quartz cuvette and its recorded signal in ellipticity (mdeg) 
converted to mean residue ellipticity (deg∙cm2∙dmol-1) by the 
following equation:
                                                                                                                  
                                                                                     [𝜃] =
𝜃
10 ∙ 𝑐 ∙ 𝑙 ∙ 𝑛
(1)
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where  is the recorded ellipticity in mdeg,  is the PA 𝜃 𝑐
concentration in M,  is the light path length of the cuvette in 𝑙
cm, and  is the number of amino acid residues in the peptide 𝑛
molecules.
Thioflavin T (ThT) Assay
PA solutions were prepared by dissolving the PAs above their 
CACs first, followed by dilution in Milli-Q water to a 
concentration of 0.1 mM (pH 7.0), before being mixed with an 
identical volume of ThT aqueous solution with a concentration 
of 50 μM. After being incubated for 1 h, the fluorescence 
emission spectrum of each sample was recorded on the LS55 
fluorescence spectrometer from 460 nm to 660 nm, with the 
excitation wavelength fixed at 440 nm.
Transmission Electron Microscopy (TEM)
Samples for TEM imaging were prepared by casting 10 μL PA 
solution (5 mM for PS and PA1 and 0.5 mM for PA2, PA3 and 
PA4) on a carbon film-coated copper grid with 400 square 
mesh (Agar Scientific). Excess PA solution on the grid was 
removed with a piece of filter paper. The samples were then 
negatively stained by loading 10 μL 2% (v/v) uranyl acetate 
solution (Agar Scientific) on the grid and the excess staining 
solution removed after 30 s. Samples were allowed to dry at 
room temperature for at least 3 h before being examined on a 
JEOL-1230 TEM with an acceleration voltage of 80 kV. TEM 
images were recorded with a SIS Megaview III wide angle CCD 
camera.
MMP-1 Cleavage of Designed Peptides
40 µL of 80 µg/mL poMMP-1 (human rheumatoid synovial 
fibroblast proenzyme; Merck Millipore; catalogue number: 
444208-5UG; Lot number: 2625650; specific activity: > 100.0 
mU/mg P) was first diluted into 160 µL TNCB buffer (50 mM 
tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCl), 
150 mM sodium chloride (NaCl), 10 mM calcium 
chloride(CaCl2), and 0.05% Brij® 35, pH 7), and then activated 
by reacting with 20 µL of 50 µM p-aminophenylmercuric 
acetate (APMA) dissolved in 0.1 sodium hydroxide (NaOH) at 
37 oC for 3 h. After activation, 30 µL of MMP-1 was added to 
470 µL of each peptide solution and incubated at 37 oC. 40 µL 
aliquots of the reaction mixture were sampled at different 
time points (0, 0.5, 1, 2, 4, 8, 12, and 24 h), flash frozen in 
liquid nitrogen and stored at -20 oC until further analysis by RP-
HPLC.
    The samples were analysed on an Alliance HPLC system 
(Waters), equipped with an analytical RP C18 column (XBridge, 
130 Å, 5 μm, 30 x150 mm, Waters). A mobile phase of H2O / 
ACN (0.1% TFA) under the gradient of 98% to 0% H2O from 5 
min to 35 min was utilized. The detection UV wavelength was 
set at 220 nm. The PF resulting from MMP-1 degradation was 
collected when significant UV signal appeared and then 
identified by ESI-MS. 
    To quantify the degradation rate, a series of PF solutions 
with different concentrations were prepared and injected into 
the RP-HPLC. Standard curve of PF was established by plotting 
the peak area versus concentration. The MMP-1 degradation 
efficiency for each PA was calculated by integrating the PF 
peak area in the corresponding RP-HPLC chromatogram and 
then converting into concentration from the standard curve 
(Fig. S12†). Data is presented as average values from three 
independent experiments with error bars representing the 
standard deviation.
Conclusions
A series of PAs, all comprising the same MMP-1 cleavable 
domain but with variations in the sequence and location of the 
secondary structure promoting segment, were utilized to 
probe the hydrolysis of their assemblies by MMP-1. We found 
that through rational molecular design, the self-assembly 
behaviour of PAs could be tuned, leading to variations in their 
CACs, secondary structures, assembled morphologies, and 
most notably their susceptibility to MMP-1 degradation. 
Adding a hydrophobic tail to the MMP-1 cleavable peptide 
sequence, as well as self-assembly, reduced the MMP-1 
degradation efficiency. Additionally, tuneable degradability of 
the PA nanofibers by MMP-1 could be achieved by tweaking 
their secondary structures, adjusted primarily through the 
deletion or alteration of the secondary structure promoting 
segments in the PA molecules. To the best of our knowledge, 
this is the first demonstration that the β-sheet composition in 
supramolecular PA nanostructures influences their 
susceptibility to MMP-1 degradation. We believe our findings 
provide fundamental insights into the generic design of MMP-
1 responsive supramolecular peptide biomaterials, which can 
be further exploited as ECM mimics, tissue engineering 
scaffolds, as well as drug delivery vehicles.
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